Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pseudoephedrine hydrochloride?Novolin n vs novolog?Cost plus drugs tadalafil 5mg price?Trazodone zydus vs teva?Medroxyprogesterone 10mg price?
See the DrugPatentWatch profile for Secukinumab
Secukinumab (the active ingredient in the psoriasis and psoriatic arthritis medicines Cosentyx) is made by Novartis.
In many markets, secukinumab is marketed under the brand name Cosentyx. Novartis is the company behind the product.
Secukinumab is also associated with other entities only through distribution or supply arrangements, but the originating manufacturer and product holder for Cosentyx is Novartis. Sources: 1. DrugPatentWatch.com – secukinumab
Other Questions About Secukinumab :